cilazapril, anhydrous has been researched along with Diabetic Angiopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Wanibuchi, H; Yamanaka, S | 1 |
| Patumraj, S; Udayachalerm, W; Vechakarn, O | 1 |
2 other study(ies) available for cilazapril, anhydrous and Diabetic Angiopathies
| Article | Year |
|---|---|
Angiotensin blockade improves cardiac and renal complications of type II diabetic rats.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cilazapril; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Glucose Tolerance Test; Imidazoles; Insulin; Male; Proteinuria; Pyridines; Rats; Rats, Inbred Strains | 1997 |
Effects of ACE-I on diabetic cardiovascular complications: anti-hypertensive and non-antihypertensive doses.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Cilazapril; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Male; Probability; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity; Streptozocin | 2001 |